|
| 36150828 | Recurring germline mosaicism in a family due to reversion of an inherited derivative chromosome 8 from an 8;21 translocation with interstitial telomeric sequences. | J Med Genet | 2023 |
| 35759000 | Variants in genes coding for collagen type IV α-chains are frequent causes of persistent, isolated hematuria during childhood. | Pediatr Nephrol | 2023 |
| 36150828 | Recurring germline mosaicism in a family due to reversion of an inherited derivative chromosome 8 from an 8;21 translocation with interstitial telomeric sequences. | J Med Genet | 2023 |
| 35759000 | Variants in genes coding for collagen type IV α-chains are frequent causes of persistent, isolated hematuria during childhood. | Pediatr Nephrol | 2023 |
| 35134542 | CYP2C8, CYP2C9, and CYP2C19 Characterization Using Next-Generation Sequencing and Haplotype Analysis: A GeT-RM Collaborative Project. | J Mol Diagn | 2022 |
| 35190513 | Accuracy and applications of sequencing and genotyping approaches for CYP2A6 and homologous genes. | Pharmacogenet Genomics | 2022 |
| 35134542 | CYP2C8, CYP2C9, and CYP2C19 Characterization Using Next-Generation Sequencing and Haplotype Analysis: A GeT-RM Collaborative Project. | J Mol Diagn | 2022 |
| 35331649 | Implementation of preemptive DNA sequence-based pharmacogenomics testing across a large academic medical center: The Mayo-Baylor RIGHT 10K Study. | Genet Med | 2022 |
| 35190513 | Accuracy and applications of sequencing and genotyping approaches for CYP2A6 and homologous genes. | Pharmacogenet Genomics | 2022 |
| 35331649 | Implementation of preemptive DNA sequence-based pharmacogenomics testing across a large academic medical center: The Mayo-Baylor RIGHT 10K Study. | Genet Med | 2022 |
| 34147031 | Novel Anaplastic Thyroid Cancer PDXs and Cell Lines: Expanding Preclinical Models of Genetic Diversity. | J Clin Endocrinol Metab | 2021 |
| 34120183 | A High-throughput Approach to Identify Effective Systemic Agents for the Treatment of Anaplastic Thyroid Carcinoma. | J Clin Endocrinol Metab | 2021 |
| 34147031 | Novel Anaplastic Thyroid Cancer PDXs and Cell Lines: Expanding Preclinical Models of Genetic Diversity. | J Clin Endocrinol Metab | 2021 |
| 34120183 | A High-throughput Approach to Identify Effective Systemic Agents for the Treatment of Anaplastic Thyroid Carcinoma. | J Clin Endocrinol Metab | 2021 |
| 31378813 | Cohort Profile: The Right Drug, Right Dose, Right Time: Using Genomic Data to Individualize Treatment Protocol (RIGHT Protocol). | Int J Epidemiol | 2020 |
| 31378813 | Cohort Profile: The Right Drug, Right Dose, Right Time: Using Genomic Data to Individualize Treatment Protocol (RIGHT Protocol). | Int J Epidemiol | 2020 |
| 31241144 | Pharmacogenomics of Nicotine Metabolism: Novel CYP2A6 and CYP2B6 Genetic Variation Patterns in Alaska Native and American Indian Populations. | Nicotine Tob Res | 2020 |
| 31241144 | Pharmacogenomics of Nicotine Metabolism: Novel CYP2A6 and CYP2B6 Genetic Variation Patterns in Alaska Native and American Indian Populations. | Nicotine Tob Res | 2020 |
| 30633344 | Neurodevelopmental disorder with dysmorphic facies and distal limb anomalies syndrome due to disruption of BPTF in a 35-year-old man initially diagnosed with Silver-Russell syndrome. | Clin Genet | 2019 |
| 30633344 | Neurodevelopmental disorder with dysmorphic facies and distal limb anomalies syndrome due to disruption of BPTF in a 35-year-old man initially diagnosed with Silver-Russell syndrome. | Clin Genet | 2019 |
| 30745309 | Pharmacogenomic Next-Generation DNA Sequencing: Lessons from the Identification and Functional Characterization of Variants of Unknown Significance in <i>CYP2C9</i> and <i>CYP2C19</i>. | Drug Metab Dispos | 2019 |
| 30784602 | Whole-Organ Genomic Characterization of Mucosal Field Effects Initiating Bladder Carcinogenesis. | Cell Rep | 2019 |
| 30784602 | Whole-Organ Genomic Characterization of Mucosal Field Effects Initiating Bladder Carcinogenesis. | Cell Rep | 2019 |
| 30745309 | Pharmacogenomic Next-Generation DNA Sequencing: Lessons from the Identification and Functional Characterization of Variants of Unknown Significance in <i>CYP2C9</i> and <i>CYP2C19</i>. | Drug Metab Dispos | 2019 |
| 29232328 | Novel CYP2A6 diplotypes identified through next-generation sequencing are associated with in-vitro and in-vivo nicotine metabolism. | Pharmacogenet Genomics | 2018 |
| 29925376 | Blood pressure signature genes and blood pressure response to thiazide diuretics: results from the PEAR and PEAR-2 studies. | BMC Med Genomics | 2018 |
| 30289819 | Targeted sequencing identifies a missense variant in the BEST3 gene associated with antihypertensive response to hydrochlorothiazide. | Pharmacogenet Genomics | 2018 |
| 29483503 | Allelic decomposition and exact genotyping of highly polymorphic and structurally variant genes. | Nat Commun | 2018 |
| 29650764 | Genetic Variants Influencing Plasma Renin Activity in Hypertensive Patients From the PEAR Study (Pharmacogenomic Evaluation of Antihypertensive Responses). | Circ Genom Precis Med | 2018 |
| 29232328 | Novel CYP2A6 diplotypes identified through next-generation sequencing are associated with in-vitro and in-vivo nicotine metabolism. | Pharmacogenet Genomics | 2018 |
| 29925376 | Blood pressure signature genes and blood pressure response to thiazide diuretics: results from the PEAR and PEAR-2 studies. | BMC Med Genomics | 2018 |
| 30289819 | Targeted sequencing identifies a missense variant in the BEST3 gene associated with antihypertensive response to hydrochlorothiazide. | Pharmacogenet Genomics | 2018 |
| 29483503 | Allelic decomposition and exact genotyping of highly polymorphic and structurally variant genes. | Nat Commun | 2018 |
| 29650764 | Genetic Variants Influencing Plasma Renin Activity in Hypertensive Patients From the PEAR Study (Pharmacogenomic Evaluation of Antihypertensive Responses). | Circ Genom Precis Med | 2018 |
| 26856248 | Transcriptomic variation of pharmacogenes in multiple human tissues and lymphoblastoid cell lines. | Pharmacogenomics J | 2017 |
| 28856246 | Breast cancer chemoprevention pharmacogenomics: Deep sequencing and functional genomics of the <i>ZNF423</i> and <i>CTSO</i> genes. | NPJ Breast Cancer | 2017 |
| 28810920 | Erratum to: Genomic innovations, transcriptional plasticity and gene loss underlying the evolution and divergence of two highly polyphagous and invasive Helicoverpa pest species. | BMC Biol | 2017 |
| 28756777 | Genomic innovations, transcriptional plasticity and gene loss underlying the evolution and divergence of two highly polyphagous and invasive Helicoverpa pest species. | BMC Biol | 2017 |
| 29167564 | Whole Transcriptome Sequencing Analyses Reveal Molecular Markers of Blood Pressure Response to Thiazide Diuretics. | Sci Rep | 2017 |
| 26856248 | Transcriptomic variation of pharmacogenes in multiple human tissues and lymphoblastoid cell lines. | Pharmacogenomics J | 2017 |
| 28115488 | Genome-Wide Prioritization and Transcriptomics Reveal Novel Signatures Associated With Thiazide Diuretics Blood Pressure Response. | Circ Cardiovasc Genet | 2017 |
| 28115488 | Genome-Wide Prioritization and Transcriptomics Reveal Novel Signatures Associated With Thiazide Diuretics Blood Pressure Response. | Circ Cardiovasc Genet | 2017 |
| 29167564 | Whole Transcriptome Sequencing Analyses Reveal Molecular Markers of Blood Pressure Response to Thiazide Diuretics. | Sci Rep | 2017 |
| 28756777 | Genomic innovations, transcriptional plasticity and gene loss underlying the evolution and divergence of two highly polyphagous and invasive Helicoverpa pest species. | BMC Biol | 2017 |
| 28810920 | Erratum to: Genomic innovations, transcriptional plasticity and gene loss underlying the evolution and divergence of two highly polyphagous and invasive Helicoverpa pest species. | BMC Biol | 2017 |
| 28856246 | Breast cancer chemoprevention pharmacogenomics: Deep sequencing and functional genomics of the <i>ZNF423</i> and <i>CTSO</i> genes. | NPJ Breast Cancer | 2017 |
| 26736087 | PGRNseq: a targeted capture sequencing panel for pharmacogenetic research and implementation. | Pharmacogenet Genomics | 2016 |
| 27435932 | Postmortem genetic screening for the identification, verification, and reporting of genetic variants contributing to the sudden death of the young. | Genome Res | 2016 |
| 26736087 | PGRNseq: a targeted capture sequencing panel for pharmacogenetic research and implementation. | Pharmacogenet Genomics | 2016 |
| 27412853 | The ethics of conducting molecular autopsies in cases of sudden death in the young. | Genome Res | 2016 |